Cargando…
Chemotherapy for gastric cancer patients – time for personalization in medicine?
Gastric cancer is one of the most frequent neoplasms. Although the incidence of gastric cancer worldwide has declined, there is still high mortality. Treatment of inoperable disease is under evaluation in clinical trials. In palliative treatment chemotherapy containing cisplatin and 5-fluorouracil i...
Autores principales: | Nowara, Elżbieta, Boratyn-Nowicka, Agnieszka, Polakiewicz-Gilowska, Anna, Drosik, Anna, Kustra, Magdalena, Huszno, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687385/ https://www.ncbi.nlm.nih.gov/pubmed/23788860 http://dx.doi.org/10.5114/wo.2012.27342 |
Ejemplares similares
-
The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation
por: Huszno, Joanna, et al.
Publicado: (2015) -
The influence of steroid receptor status on the cardiotoxicity risk in HER2-positive breast cancer patients receiving trastuzumab
por: Huszno, Joanna, et al.
Publicado: (2015) -
Current therapeutic strategies of anti-HER2 treatment in advanced breast cancer patients
por: Huszno, Joanna, et al.
Publicado: (2016) -
Risk factors for disease progression in HER2-positive breast cancer patients based on the location of metastases
por: Huszno, Joanna, et al.
Publicado: (2015) -
Metaplastic breast carcinomas – analysis of prognostic factors in a case series
por: Nowara, Elżbieta, et al.
Publicado: (2014)